Login / Signup

Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness.

Mark É CzeislerJustina M PruskiPan WangJingyuan WangChangfu XiaoMihael H PolymeropoulosVasilios M Polymeropoulos
Published in: PloS one (2023)
The MSSS is a valid instrument for the assessment of the core motion sickness symptoms and is reflective of global disease severity. Implementation of the MSSS and comparable simplified, short questionnaires in motion sickness research will provide rapid and accurate measures of disease severity. These measures will enable further elucidation of motion sickness as an illness and inform the development and evaluation of motion sickness therapies.
Keyphrases
  • high speed
  • double blind
  • primary care
  • healthcare
  • randomized controlled trial
  • quality improvement
  • placebo controlled
  • mass spectrometry
  • phase ii